Regulus extends gains

Regulus Therapeutics Inc. (Nasdaq: RGLS) extended its gains by soaring $2.79 to close at $17.33.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.